Find Cisatracurium Besylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

FDF DossiersDRUG PRODUCT COMPOSITIONS

4RELATED EXCIPIENT COMPANIES

5EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 96946-42-8, Nimbex, Cisatracurium besilate, Cisatracurium (besylate), 51w89, Cisatracurium besylate [usan]
Molecular Formula
C65H82N2O18S2
Molecular Weight
1243.5  g/mol
InChI Key
XXZSQOVSEBAPGS-DONVQRBFSA-L
FDA UNII
Y78PS7MEDE

Cisatracurium Besylate
Cisatracurium Besylate is the besylate salt form of cisatracurium, a non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class, with skeletal muscle relaxing activity. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. This blocks neuromuscular transmission and causes neuromuscular relaxation.
1 2D Structure

Cisatracurium Besylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
2.1.2 InChI
InChI=1S/C53H72N2O12.2C6H6O3S/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*7-10(8,9)6-4-2-1-3-5-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*1-5H,(H,7,8,9)/q+2;;/p-2/t42-,43-,54-,55-;;/m1../s1
2.1.3 InChI Key
XXZSQOVSEBAPGS-DONVQRBFSA-L
2.1.4 Canonical SMILES
C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
2.1.5 Isomeric SMILES
C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
Y78PS7MEDE
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 51w89

2. Cisatracurium

3. Cisatracurium Besilate

4. Nimbex

2.3.2 Depositor-Supplied Synonyms

1. 96946-42-8

2. Nimbex

3. Cisatracurium Besilate

4. Cisatracurium (besylate)

5. 51w89

6. Cisatracurium Besylate [usan]

7. Cisatracurium (as Besilate)

8. 80ys8o1mbs

9. Cisatracurium Besilate [inn]

10. Chebi:3721

11. (1r,1'r,2r,2'r)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) Benzenesulfonate

12. 96946-42-8 (besylate)

13. (1r,2r)-2-(2-carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium Benzenesulfonate, Pentamethylene Ester

14. (1r-cis,1'r-cis)-atracurium Besylate

15. 51-w89

16. 51w-89

17. 51-w-89

18. Cisatracurium Besilate (inn)

19. Nimbex Preservative Free

20. Cis-atracurium Besylate

21. Unii-80ys8o1mbs

22. Nimbium

23. Atracurium Besylate 1r-cis,1r'-cis Form

24. Nimbex Forte

25. Ncgc00017127-01

26. Cas-64228-81-5

27. Nimbex (tn)

28. Cisatracurium Besylate Preservative Free

29. Cis-atracurium Besilate

30. Isoquinolinium,2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,(1r,1'r,2r,2'r)-, Dibenzenesulfonate

31. Y78ps7mede

32. Schembl40669

33. Cisatracurium Besylate (usp)

34. Cisatracurium Dibenzenesulfonate

35. Cisatracurium Besylate (nimbex)

36. Chembl1200641

37. Cisatracurium Besylate (~90%)

38. Dtxsid10895045

39. Hms3715p04

40. Hms3884l07

41. Cisatracurium Besylate [mi]

42. Benzenesulfonate;5-[3-[(1r,2r)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1r,2r)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-2-ium-2-yl]propanoate

43. Ex-a2646

44. Mfcd00871018

45. S2113

46. Cisatracurium Besylate [vandf]

47. Akos026750111

48. Cisatracurium Besilate [mart.]

49. Ccg-221271

50. Cisatracurium Besilate [who-dd]

51. Cisatracurium Besylate [usp-rs]

52. (1r,2r,1'r,2'r)-atracurium Besylate

53. Bs-17985

54. Hy-13596

55. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, Dibenzenesulfonate, (1r-(1alpha,2alpha(1'r(sup *),2'r(sup *))))-

56. Cisatracurium Besylate [orange Book]

57. Cisatracurium Besilate [ep Monograph]

58. Sw222230-1

59. Cisatracurium Besylate [usp Monograph]

60. 51 W89

61. D00759

62. Q267669

63. W-60404

64. Z2216208615

65. Atracurium Besylate, (1r,1'r,2r,2'r)-(+/-)-

66. Cisatracurium Besilate, Europepharmacopoeia (ep) Reference Standard

67. Cisatracurium Besylate, United States Pharmacopeia (usp) Reference Standard

68. Cisatracurium For Peak Identification, Europepharmacopoeia (ep) Reference Standard

69. Cisatracurium For System Suitability, Europepharmacopoeia (ep) Reference Standard

70. (1r,1'r,2r,2'r)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)benzenesulfonate

71. (1r,2r)-1-[(3,4-dimethoxyphenyl)methyl]-2-(3-{[5-({3-[(1r,2r)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl]propanoyl}oxy)pentyl]oxy}-3-oxopropyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium Dibenzenesulfonate

72. (1r,2r,1'r,2'r)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] Bisbenzenesulfonate

73. (1r-cis,1'r-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] Bisbenzenesulfonate

74. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1r,1'r,2r,2'r)-, Benzenesulfonate (1:2)

75. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1r,1'r,2r,2'r)-, Dibenzenesulfonate

76. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1r,1'r,2r,2'r)-rel, Dibenzenesulfonate

77. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, Dibenzenesulfonate, (1r-(1.alpha.,2.alpha.(1'r*,2'r*)))-

78. Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, Dibenzenesulphonate, (1r-(1.alpha.,2.alpha.(1'r*,2'r*)))-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 1243.5 g/mol
Molecular Formula C65H82N2O18S2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count18
Rotatable Bond Count26
Exact Mass1242.50040612 g/mol
Monoisotopic Mass1242.50040612 g/mol
Topological Polar Surface Area258 Ų
Heavy Atom Count87
Formal Charge0
Complexity1560
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameCisatracurium besylate
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml
Market StatusPrescription
CompanySandoz

2 of 6  
Drug NameNimbex
Drug LabelNIMBEX (cisatracurium besylate) is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10...
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml
Market StatusPrescription
CompanyAbbvie

3 of 6  
Drug NameNimbex preservative free
Drug LabelCisatracurium besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10isomers...
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml; eq 10mg base/ml
Market StatusPrescription
CompanyAbbvie

4 of 6  
Drug NameCisatracurium besylate
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml
Market StatusPrescription
CompanySandoz

5 of 6  
Drug NameNimbex
Drug LabelNIMBEX (cisatracurium besylate) is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10...
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml
Market StatusPrescription
CompanyAbbvie

6 of 6  
Drug NameNimbex preservative free
Drug LabelCisatracurium besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action. Cisatracurium besylate is one of 10isomers...
Active IngredientCisatracurium besylate
Dosage FormInjectable
RouteInjection
Strengtheq 2mg base/ml; eq 10mg base/ml
Market StatusPrescription
CompanyAbbvie

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Neuromuscular Blocking Agents

Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. (See all compounds classified as Neuromuscular Blocking Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Nondepolarizing Neuromuscular Blocker [EPC]; Neuromuscular Nondepolarizing Blockade [PE]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2017-06-23

Pay. Date : 2017-05-09

DMF Number : 23554

Submission : 2010-02-21

Status : Active

Type : II

Seqens Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2020-04-14

Pay. Date : 2020-04-09

DMF Number : 24999

Submission : 2011-05-30

Status : Active

Type : II

Farmhispania

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-23

Pay. Date : 2012-11-13

DMF Number : 23130

Submission : 2009-09-28

Status : Active

Type : II

TAPI Company Banner

05

USCC
Not Confirmed

06

Cf Pharma Ltd

Hungary

USDMF

arrow
USCC
Not Confirmed

07

Cf Pharma Ltd

Hungary

USDMF

arrow
USCC
Not Confirmed

07

Cf Pharma Ltd

Hungary
arrow
USCC
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-09-09

Pay. Date : 2014-01-22

DMF Number : 24969

Submission : 2012-08-27

Status : Active

Type : II

blank

08

Gland Pharma Ltd

India

USDMF

arrow
USCC
Not Confirmed

08

USCC
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-07-15

Pay. Date : 2020-06-09

DMF Number : 34425

Submission : 2019-12-26

Status : Active

Type : II

blank

09

Gland Pharma Ltd

India

USDMF

arrow
USCC
Not Confirmed

10

Gland Pharma Ltd

India

USDMF

arrow
USCC
Not Confirmed

10

click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content
CEP 2023-465 - Rev 01
Valid
Chemical
2024-10-24
2763
Seqens Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Certificate Number : CEP 2023-465 - Rev 01

Status : Valid

Issue Date : 2024-10-24

Type : Chemical

Substance Number : 2763

Seqens Company Banner
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content
CEP 2016-200 - Rev 01
Valid
Chemical
2024-10-23
2763
Seqens Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Certificate Number : CEP 2016-200 - Rev 01

Status : Valid

Issue Date : 2024-10-23

Type : Chemical

Substance Number : 2763

Seqens Company Banner
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content
R1-CEP 2016-285 - Rev 00
Valid
Chemical
2022-09-26
2763
Farmhispania

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content

Certificate Number : R1-CEP 2016-285 - Rev 00

Status : Valid

Issue Date : 2022-09-26

Type : Chemical

Substance Number : 2763

Farmhispania
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
R1-CEP 2016-093 - Rev 00
Valid
Chemical
2022-05-16
2763
TAPI Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Certificate Number : R1-CEP 2016-093 - Rev 00

Status : Valid

Issue Date : 2022-05-16

Type : Chemical

Substance Number : 2763

TAPI Company Banner

05

BIO Asia-Taiwan
Not Confirmed
arrow
arrow
BIO Asia-Taiwan
Not Confirmed

Certificate Number : R0-CEP 2021-236 - Rev 00

Status : Valid

Issue Date : 2022-09-15

Type : Chemical

Substance Number : 2763

blank

06

BIO Asia-Taiwan
Not Confirmed
arrow
arrow
BIO Asia-Taiwan
Not Confirmed

Certificate Number : CEP 2021-064 - Rev 02

Status : Valid

Issue Date : 2024-02-23

Type : Chemical

Substance Number : 2763

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Seqens

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSeqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Flag France
Digital Content Digital Content

Cisatracurium Besylate

About the Company : Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists ...

Since its inception in 2003, Seqens has evolved into a global leader in pharmaceutical solutions and specialty ingredients. With a strong focus on customer support, Seqens assists in the development, scale-up and manufacturing of drug substances from pre-clinical to commercial stages. Seqens boasts a vast portfolio of APIs and proprietary products while also developing custom solutions and ingredients for the healthcare, electronics and cosmetics industries. It operates 16 industrial plants and 9 R&D centers worldwide. Seqens possesses technologies that enable it to produce complex molecules to meet both small- and large-scale demands.
Seqens Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content

Cisatracurium Besylate

About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...

Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout the entire API life cycle, from product development through sales. Transo-Pharm serves as a sourcing and regulatory marketing agent for API manufacturers. It aids clients in establishing DMFs and provides GMP consulting. With a dedicated regulatory department, a warehouse, proprietary IPs for API processes, and partnerships with laboratories, Transo-Pharm offers a wide range of services. It operates from its offices in Shanghai, Hong Kong, Singapore, and the US.
Transo Pharm USA Company Banner

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Cisatracurium Besylate

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Flag India
Digital Content Digital Content

Cisatracurium Besylate

About the Company : Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. AP...

Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. APIs manufactured by Synnat are used by major drug formulators worldwide. Manufacturing activities are carried out as per ICH cGMP guidelines and several conventional and modern techniques are used for the isolation, semi-synthesis and purification of its products. Synnat Pharma has a presence in semi-regulated and non-regulated markets and is now entering regulated markets.
Synnat

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Cisatracurium Besylate

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

06

Farmhispania

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFarmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

Flag Spain
Digital Content Digital Content

Cisatracurium Besylate

About the Company : Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipmen...

Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipment, new technologies, and enhanced capabilities. Significant investments include the implementation of hydrogenation technologies in 2007, HPAPI handling capabilities in 2010, highly potent fermentation capabilities in 2014, and the expansion of large-scale preparative chromatography in 2015. Additionally, Farmhispania Group actively collaborates on numerous projects with various universities and research organizations both nationally and internationally.
Farmhispania

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Cisatracurium Besylate

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

08

BIO Asia-Taiwan
Not Confirmed
arrow
arrow
BIO Asia-Taiwan
Not Confirmed

Cisatracurium

About the Company : A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his...

A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju, who has always thought far ahead of his time. Since inception, Gland Pharma stands testimony to the founder’s exemplary commitment to Quality, having emerged as a global player with presence in about 90 countries in five continents. We have a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions.
blank

09

BIO Asia-Taiwan
Not Confirmed
arrow
arrow
BIO Asia-Taiwan
Not Confirmed

Cisatracurium

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

10

BIO Asia-Taiwan
Not Confirmed
arrow
arrow
BIO Asia-Taiwan
Not Confirmed

Cisatracurium Besylate

About the Company : Founded in 2000, YONSUNG fine chemicals co., Ltd. is a top quality, fast growing manufacturer of APIs, especially, PROSTAGLANDINS and related products for pharmaceutical applicatio...

Founded in 2000, YONSUNG fine chemicals co., Ltd. is a top quality, fast growing manufacturer of APIs, especially, PROSTAGLANDINS and related products for pharmaceutical applications. YONSUNG prides itself on the quality of its products, which gives the company an important competitive edge. The site manufactures API,s for the US, EU and other regulated markets and complies with the cGMP guidelines established by ICH (Q7A). The relevance of new requirements from the FDA, ICH, EMEA and EDQM is continuously monitored.Stringent controls are built-in to ensure that every single product meets the specification of most known pharmacopeias.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713983400,"product":"CISATRACURIUM BESYLATE 1-METHYLPENTANEDIOL ANALOG (QTY 600 MG, VALUE USD 1761)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAINDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIAL CONVENT","customerCountry":"UNITED STATES","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"293500","totalValueFC":"1744","currency":"USD","unitRateINR":24272429.999999996,"date":"25-Apr-2024","totalValueINR":"145634.58","totalValueInUsd":"1744","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"9375243","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,, TURKAPALLY(V),SHAMEERPET, HYDERABAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1644258600,"product":"(FOC) - CISATRACURIUM BESYLATE - 31179 - 3117900068","address":"NO.54\/1, BOODIHAL,,NELAMANGALA,","city":"BENGALURU,KARNATAKA","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"SOMERSET THERAPEUTICS LTD","customerCountry":"INDIA","quantity":"10.46","actualQuantity":"10.462","unit":"KGS","unitRateFc":"40320","totalValueFC":"426291.1","currency":"USD","unitRateINR":"3054240","date":"08-Feb-2022","totalValueINR":"31953458.88","totalValueInUsd":"426291.1","indian_port":"BANGALORE AIR","hs_no":"29334900","bill_no":"7408037","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO.54\/1, BOODIHAL,,NELAMANGALA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1650306600,"product":"CISATRACURIUM BESYLATE USP QUANTITY 1.00 KGS","address":"11\/12, UDYOG NAGAR,,S.V. ROAD, G OREGAON WEST,","city":"MUMBAI,MAHARASHTRA","supplier":"LIANYUNGANG GUIKE PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"THEMIS MEDICARE LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"18000","totalValueFC":"18322.3","currency":"USD","unitRateINR":"1382400","date":"19-Apr-2022","totalValueINR":"1382400","totalValueInUsd":"18322.3","indian_port":"DELHI AIR","hs_no":"29420090","bill_no":"8334971","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"11\/12, UDYOG NAGAR,,S.V. ROAD, G OREGAON WEST,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653935400,"product":"CHEMICAL : CISATRACURIUM BESYLATE","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"32974.4","totalValueFC":"134140.5","currency":"USD","unitRateINR":"2591785.5","date":"31-May-2022","totalValueINR":"10367142","totalValueInUsd":"134140.5","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29334900","bill_no":"1002182","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"N\/A","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"CHEMICAL : CISATRACURIUM BESYLATE PH.EUR.","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.21","actualQuantity":"1210","unit":"GMS","unitRateFc":"40","totalValueFC":"48979.9","currency":"USD","unitRateINR":"3158","date":"18-Jun-2022","totalValueINR":"3821180","totalValueInUsd":"48979.9","indian_port":"AHMEDABAD AIR","hs_no":"29334900","bill_no":"9171114","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,, S.G. HIGHWAY, THALTEJ"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656700200,"product":"CISATRACURIUM BESYLATE USP","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"3.69","actualQuantity":"3.694","unit":"KGS","unitRateFc":"50000","totalValueFC":"183384","currency":"USD","unitRateINR":"3947500","date":"02-Jul-2022","totalValueINR":"14582065","totalValueInUsd":"183384","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"9386795","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656959400,"product":"CISATRACURIUM BESYLATE - 74014AO - BATCH# 4014AO01522 (QTY 1KGS)","address":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,","city":"HYDERABAD,TELANGANA","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"60000","totalValueFC":"59572.5","currency":"USD","unitRateINR":"4737000","date":"05-Jul-2022","totalValueINR":"4737000","totalValueInUsd":"59572.5","indian_port":"BANGALORE AIR","hs_no":"29334900","bill_no":"9419976","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"564\/A\/22, ROAD NO. 92,JUBILEE HILL S,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662316200,"product":"CISATRACURIUM BESYLATE USP","address":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE","city":"AHMEDABAD","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"2.92","actualQuantity":"2.918","unit":"KGS","unitRateFc":"50000","totalValueFC":"146462.5","currency":"USD","unitRateINR":"4022500","date":"05-Sep-2022","totalValueINR":"11737655","totalValueInUsd":"146462.5","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"2310620","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO 63, KHORAJ (GANDHINAGAR), NR. VAISHNODE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664994600,"product":"CISATRACURIUM BESYLATE (0.460KG)","address":"SHANKAR TOWERS PLOT NO. A30,A.I.E BALANAGAR HYDERABAD","city":"HYDERABAD,TELANGANA","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"ANTHEA PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"0.46","actualQuantity":"0.46","unit":"KGS","unitRateFc":"54000","totalValueFC":"24271.2","currency":"USD","unitRateINR":"4341600","date":"06-Oct-2022","totalValueINR":"1997136","totalValueInUsd":"24271.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2762972","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SHANKAR TOWERS PLOT NO. A30,A.I.E BALANAGAR HYDERABAD"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670869800,"product":"CISATRACURIUM BESYLATE USP","address":"NO 28 BHANGWADI SHOPPING ARCADE*BHANGWADI","city":"BOMBAY ,MAHARASHTRA","supplier":"GUANGZHOU CHEERLAND IMPORT EXPORT LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"RUSKIN CHEMIPHARM","customerCountry":"INDIA","quantity":"0.56","actualQuantity":"0.56","unit":"KGS","unitRateFc":"20000","totalValueFC":"11144.8","currency":"USD","unitRateINR":"1640000","date":"13-Dec-2022","totalValueINR":"918400","totalValueInUsd":"11144.8","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"3720696","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO 28 BHANGWADI SHOPPING ARCADE*BHANGWADI"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1671129000,"product":"31179 CISATRACURIUM BESYLATE ( 500 GRM) ( TEST LICENCE NO. TL\/NZ\/22\/000299 DATE 06.05.2022) ( R & D PURPOSE)","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III","city":"NEW DELHI,DELHI","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"36000","totalValueFC":"19593.2","currency":"EURO","unitRateINR":"3229200","date":"16-Dec-2022","totalValueINR":"1614600","totalValueInUsd":"19593.2","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"3769298","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672338600,"product":"CISATRACURIUM BESYLATE","address":"Ashvich Towers Plot No.3 Developed Plots Industria","city":"CHENNAI","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"NA","customer":"CAPLIN STERILES LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"55000","totalValueFC":"1672.9","currency":"USD","unitRateINR":"4595250","date":"30-Dec-2022","totalValueINR":"137857.5","totalValueInUsd":"1672.9","indian_port":"MADRAS AIR","hs_no":"29334900","bill_no":"3968005","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Ashvich Towers Plot No.3 Developed Plots Industria"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679855400,"product":"31179 CISATRACURIUM BESYLATE TEST LICENCE NO. TL\/NZ\/22\/000299 DATE 06.05.2022) ( R & D PURPOSE)","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III","city":"NEW DELHI,DELHI","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.64","actualQuantity":"0.64","unit":"KGS","unitRateFc":"39130","totalValueFC":"27204.9","currency":"EURO","unitRateINR":"3496265.5","date":"27-Mar-2023","totalValueINR":"2237609.92","totalValueInUsd":"27204.9","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"5243901","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680201000,"product":"CISATRACURIUM BESYLATE USP","address":"NO 28 BHANGWADI SHOPPING ARCADE*BHANGWADI","city":"BOMBAY ,MAHARASHTRA","supplier":"GUANGZHOU CHEERLAND IMPORT EXPORT LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"RUSKIN CHEMIPHARM","customerCountry":"INDIA","quantity":"1.70","actualQuantity":"1.7","unit":"KGS","unitRateFc":"22000","totalValueFC":"38059.2","currency":"USD","unitRateINR":"1841400","date":"31-Mar-2023","totalValueINR":"3130380","totalValueInUsd":"38059.2","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"5315510","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO 28 BHANGWADI SHOPPING ARCADE*BHANGWADI"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691087400,"product":"CISATRACURIUM BESYLATE API","address":"NO. 9\/215, PUDUPAKKAM - VANDALLUR, MAIN ROAD PUDUPAKKAM","city":"KELAMBAKKAM","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"NA","customer":"PAR FORMULATIONS PRIVATE LTD","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"32000","totalValueFC":"9669.1","currency":"USD","unitRateINR":"2643151.1","date":"04-Aug-2023","totalValueINR":"800954.88","totalValueInUsd":"9669.1","indian_port":"SAHAR AIR","hs_no":"29334900","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"NO. 9\/215, PUDUPAKKAM - VANDALLUR, MAIN ROAD PUDUPAKKAM"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"CISATRACURIUM BESYLATE","address":"HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"PIRAMAL PHARMA SOLUTIONS","supplierCountry":"ITALY","foreign_port":"WASHINGTON, DULLES I","customer":"ASPIRO PHARMA LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"49000","totalValueFC":"49582.7","currency":"USD","unitRateINR":"4120900","date":"22-Jan-2024","totalValueINR":"4120900","totalValueInUsd":"49582.7","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"9767984","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"1575 MCGRATHIANA PKWY LEXINGTON, KY, 40511 UNITED STATESSDNF United States","customerAddress":"HETERO HOUSE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707503400,"product":"(FOC) - CISATRACURIUM BESYLATE - 31179","address":"REGD. OFFICE: NO. 16\/2,","city":"BANGALORE, KARNATAKA","supplier":"FARMHISPANIA S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"SOMERSET THERAPEUTICS LTD","customerCountry":"INDIA","quantity":"21.88","actualQuantity":"21.875","unit":"KGS","unitRateFc":"23000","totalValueFC":"554521.9","currency":"EURO","unitRateINR":"2103350","date":"10-Feb-2024","totalValueINR":"46010781.25","totalValueInUsd":"554521.9","indian_port":"Bangalore Air","hs_no":"29334900","bill_no":"2089667","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"PASSEIG RIU BESOS 9-10 08160 MONTMELO Barcelona, , SpainSDNF Spain","customerAddress":"REGD. OFFICE: NO. 16\/2,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"CISATRACURIUM BESYLATE USP","address":"NO 28","city":"BOMBAY ,MAHARASHTRA","supplier":"GUANGZHOU CHEERLAND IMPORT EXPORT LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"RUSKIN CHEMIPHARM","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"19000","totalValueFC":"19163.4","currency":"USD","unitRateINR":"1591250","date":"22-Mar-2024","totalValueINR":"1591250","totalValueInUsd":"19163.4","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2695287","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"RM NO.703-2,363 DONG FENG ZHONG ROAD, GUANGZHOU, CHINA , , CHINASDNF CHINA","customerAddress":"NO 28"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.53","actualQuantity":"526","unit":"GMS","unitRateFc":"40","totalValueFC":"21252.3","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"1774724","totalValueInUsd":"21252.3","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"997","unit":"GMS","unitRateFc":"40","totalValueFC":"40282.4","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"3363878","totalValueInUsd":"40282.4","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.07","actualQuantity":"1071","unit":"GMS","unitRateFc":"40","totalValueFC":"43272.3","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"3613554","totalValueInUsd":"43272.3","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.25","actualQuantity":"1254","unit":"GMS","unitRateFc":"40","totalValueFC":"50666.2","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"4230996","totalValueInUsd":"50666.2","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1.65","actualQuantity":"1650","unit":"GMS","unitRateFc":"40","totalValueFC":"66666","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"5567100","totalValueInUsd":"66666","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712341800,"product":"CISATRACURIUM BESYLATE EP\/BP\/IP\/USP\/PH.EUR. (CISATRACURIUM BESYLATE PH. EUR.)","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2.26","actualQuantity":"2255","unit":"GMS","unitRateFc":"40","totalValueFC":"91110.2","currency":"USD","unitRateINR":"3374","date":"06-Apr-2024","totalValueINR":"7608370","totalValueInUsd":"91110.2","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"2913084","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"Piet Hein Building, Piet Heinkade 107 1019 GM Amsterdam The Netherlands Amsterdam, , Netherlands Tel.:31- Netherlands","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1716748200,"product":"CISATRACURIUM BESYLATE USP","address":"NO 28","city":"BOMBAY ,MAHARASHTRA","supplier":"GUANGZHOU CHEERLAND IMPORT EXPORT LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"RUSKIN CHEMIPHARM","customerCountry":"INDIA","quantity":"2.10","actualQuantity":"2.1","unit":"KGS","unitRateFc":"19000","totalValueFC":"40376.7","currency":"USD","unitRateINR":"1602650","date":"27-May-2024","totalValueINR":"3365565","totalValueInUsd":"40376.7","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"3681229","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"RM NO.703-2,363 DONG FENG ZHONG ROAD, GUANGZHOU, CHINA , , CHINASDNF CHINA","customerAddress":"NO 28"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719599400,"product":"CISATRACURIUM BESYLATE USP","address":"NARBAVI NO3 LAKSHMANAN STREET,,T.N","city":"CHENNAI,TAMIL NADU","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN","customer":"CAPLIN STERILES LTD","customerCountry":"INDIA","quantity":"0.84","actualQuantity":"0.84","unit":"KGS","unitRateFc":"35000","totalValueFC":"29689","currency":"USD","unitRateINR":"2950500","date":"29-Jun-2024","totalValueINR":"2478420","totalValueInUsd":"29689","indian_port":"Madras Air","hs_no":"29334900","bill_no":"4250052","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN","supplierAddress":"PIET HEIN BUILDING PIET HEINKADA107, 1019 GMAMSTERDAM NL","customerAddress":"NARBAVI NO3 LAKSHMANAN STREET,,T.N"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722018600,"product":"CISATRACURIUM BESYLATE","address":"HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"PIRAMAL PHARMA SOLUTIONS INC","supplierCountry":"ITALY","foreign_port":"NEW YORK - JOHN F. K","customer":"ASPIRO PHARMA LTD","customerCountry":"INDIA","quantity":"1.90","actualQuantity":"1.9","unit":"KGS","unitRateFc":"49000","totalValueFC":"94168","currency":"USD","unitRateINR":"4142950","date":"27-Jul-2024","totalValueINR":"7871605","totalValueInUsd":"94168","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"4724317","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NEW YORK - JOHN F. K","supplierAddress":"1575 MCGRATHIANA PKWY LEXINGTON, KY, 40511SDNF United States","customerAddress":"HETERO HOUSE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1727893800,"product":"CISATRACURIUM BESYLATE. ITEM NO. 74014AO. LOT NO. 4014AO02824 MFGF. JULY 2024. EXP. DATE JULY 2027","address":"CORPORATE HOUSE, NR. SOLA BRIDGE,,","city":"AHMEDABAD,GUJARAT","supplier":"TEVA API BV","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"INTAS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"3.96","actualQuantity":"3.963","unit":"KGS","unitRateFc":"40000","totalValueFC":"159601.8","currency":"USD","unitRateINR":"3384000","date":"03-Oct-2024","totalValueINR":"13410792","totalValueInUsd":"159601.8","indian_port":"Ahmedabad Air","hs_no":"29334900","bill_no":"5920038","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"PIET HEINKADE 107 GM AMSTERDAM, 010 19 HOLLAND Amsterdam, , NETHERLANDS SDNF NETHERLANDS","customerAddress":"CORPORATE HOUSE, NR. SOLA BRIDGE,,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1744655400,"product":"CISATRACURIUM BESYLATE (FREE OF CHARGE) CISATRACURIUM BESYLATE","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"SOCIETA ITALIANA CORTICOSTEROIDI SRL","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"JODAS EXPOIM PRIVATE LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"24101.7","totalValueFC":"146.3","currency":"USD","unitRateINR":"2087205","date":"15-Apr-2025","totalValueINR":"12523.23","totalValueInUsd":"146.3","indian_port":"Hyderabad Air","hs_no":"29334900","bill_no":"9490192","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"SEDE LEGALE PIAZZALE L CADOMA 4 20 123 MILANO SDNF Italy","customerAddress":"101, SITARAM MANSION,"}]
08-Feb-2022
15-Apr-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Listed Dossiers

read-more
read-more

01

Pharmathen SA

Greece
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Flag Greece
Digital Content Digital Content

Regulatory Info : EU Approved

Registration Country : Greece

Cisatracurium Besylate

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

01

Pharmathen SA

Greece
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Flag Greece
Digital Content Digital Content

Packaging :

Regulatory Info : EU Approved

Cisatracurium Besylate

Dosage : Solution For Injection

Dosage Strength : 2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Pharmathen

02

Pharmathen SA

Greece
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Flag Greece
Digital Content Digital Content

Regulatory Info : EU Approved

Registration Country : Greece

Cisatracurium Besylate

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : EU Approved

Registration Country : Greece

Pharmathen

02

Pharmathen SA

Greece
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Flag Greece
Digital Content Digital Content

Packaging :

Regulatory Info : EU Approved

Cisatracurium Besylate

Dosage : Solution For Injection

Dosage Strength : 5MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Greece

Pharmathen

03

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Injection

Dosage Strength : 10MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

04

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Injection

Dosage Strength : 10MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

05

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Injection

Dosage Strength : 2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

Farbe Firma

India
USCC
Not Confirmed
arrow

Farbe Firma

India
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Injection

Dosage Strength : 2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

06

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Vial

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Vial

Dosage Strength : 10MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

07

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name : Cisatracurium Besylate

Dosage Form : Liquid Injection

Dosage Strength : 2MG/ML

Packaging : 25 ML, 5 ML, 10 ML

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Liquid Injection

Dosage Strength : 2MG/ML

Brand Name : Cisatracurium Besylate

Approval Date :

Application Number :

Registration Country : India

blank

08

MS Pharma

Jordan
USCC
Not Confirmed
arrow

MS Pharma

Jordan
arrow
USCC
Not Confirmed

Cisatracurium

Brand Name :

Dosage Form : SOLUTION

Dosage Strength : 2MG/ML

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info : Generic CTD- Available

Registration Country : Jordan

blank

08

MS Pharma

Jordan
USCC
Not Confirmed
arrow

MS Pharma

Jordan
arrow
USCC
Not Confirmed

Cisatracurium

Dosage : SOLUTION

Dosage Strength : 2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Jordan

blank

09

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Liquid Injection

Dosage Strength : 2MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

09

USCC
Not Confirmed
arrow
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Liquid Injection

Dosage Strength : 2MG/ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

Pluviaendo

Turkey
USCC
Not Confirmed
arrow

Pluviaendo

Turkey
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Brand Name :

Dosage Form : Ampoule

Dosage Strength : 10MG/5ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

10

Pluviaendo

Turkey
USCC
Not Confirmed
arrow

Pluviaendo

Turkey
arrow
USCC
Not Confirmed

Cisatracurium Besylate

Dosage : Ampoule

Dosage Strength : 10MG/5ML

Brand Name :

Approval Date :

Application Number :

Registration Country : Turkey

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - EQ 10MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20551

read-more

DOSAGE - INJECTABLE;INJECTION - EQ 2MG BASE/M...DOSAGE - INJECTABLE;INJECTION - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20551

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 96946-42-8 / Cisatracurium Besylate API manufacturers, exporters & distributors?

Cisatracurium Besylate manufacturers, exporters & distributors 1

65

PharmaCompass offers a list of Cisatracurium Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cisatracurium Besylate manufacturer or Cisatracurium Besylate supplier.

PharmaCompass also assists you with knowing the Cisatracurium Besylate API Price utilized in the formulation of products. Cisatracurium Besylate API Price is not always fixed or binding as the Cisatracurium Besylate Price is obtained through a variety of data sources. The Cisatracurium Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cisatracurium Besylate

Synonyms

96946-42-8, Nimbex, Cisatracurium besilate, Cisatracurium (besylate), 51w89, Cisatracurium besylate [usan]

Cas Number

96946-42-8

Unique Ingredient Identifier (UNII)

Y78PS7MEDE

About Cisatracurium Besylate

Cisatracurium Besylate is the besylate salt form of cisatracurium, a non-depolarizing skeletal muscle relaxant of the benzylisoquinolinium class, with skeletal muscle relaxing activity. Cisatracurium besylate acts as a competitive acetylcholine antagonist that binds to nicotinic receptors at the neuromuscular junction. This blocks neuromuscular transmission and causes neuromuscular relaxation.

Cisatracurium Besylate Manufacturers

A Cisatracurium Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cisatracurium Besylate, including repackagers and relabelers. The FDA regulates Cisatracurium Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cisatracurium Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cisatracurium Besylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cisatracurium Besylate Suppliers

A Cisatracurium Besylate supplier is an individual or a company that provides Cisatracurium Besylate active pharmaceutical ingredient (API) or Cisatracurium Besylate finished formulations upon request. The Cisatracurium Besylate suppliers may include Cisatracurium Besylate API manufacturers, exporters, distributors and traders.

click here to find a list of Cisatracurium Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cisatracurium Besylate USDMF

A Cisatracurium Besylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cisatracurium Besylate active pharmaceutical ingredient (API) in detail. Different forms of Cisatracurium Besylate DMFs exist exist since differing nations have different regulations, such as Cisatracurium Besylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Cisatracurium Besylate DMF submitted to regulatory agencies in the US is known as a USDMF. Cisatracurium Besylate USDMF includes data on Cisatracurium Besylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cisatracurium Besylate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Cisatracurium Besylate suppliers with USDMF on PharmaCompass.

Cisatracurium Besylate CEP

A Cisatracurium Besylate CEP of the European Pharmacopoeia monograph is often referred to as a Cisatracurium Besylate Certificate of Suitability (COS). The purpose of a Cisatracurium Besylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cisatracurium Besylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cisatracurium Besylate to their clients by showing that a Cisatracurium Besylate CEP has been issued for it. The manufacturer submits a Cisatracurium Besylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cisatracurium Besylate CEP holder for the record. Additionally, the data presented in the Cisatracurium Besylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cisatracurium Besylate DMF.

A Cisatracurium Besylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cisatracurium Besylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Cisatracurium Besylate suppliers with CEP (COS) on PharmaCompass.

Cisatracurium Besylate WC

A Cisatracurium Besylate written confirmation (Cisatracurium Besylate WC) is an official document issued by a regulatory agency to a Cisatracurium Besylate manufacturer, verifying that the manufacturing facility of a Cisatracurium Besylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cisatracurium Besylate APIs or Cisatracurium Besylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Cisatracurium Besylate WC (written confirmation) as part of the regulatory process.

click here to find a list of Cisatracurium Besylate suppliers with Written Confirmation (WC) on PharmaCompass.

Cisatracurium Besylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cisatracurium Besylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cisatracurium Besylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cisatracurium Besylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cisatracurium Besylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cisatracurium Besylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cisatracurium Besylate suppliers with NDC on PharmaCompass.

Cisatracurium Besylate GMP

Cisatracurium Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cisatracurium Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cisatracurium Besylate GMP manufacturer or Cisatracurium Besylate GMP API supplier for your needs.

Cisatracurium Besylate CoA

A Cisatracurium Besylate CoA (Certificate of Analysis) is a formal document that attests to Cisatracurium Besylate's compliance with Cisatracurium Besylate specifications and serves as a tool for batch-level quality control.

Cisatracurium Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Cisatracurium Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cisatracurium Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cisatracurium Besylate EP), Cisatracurium Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cisatracurium Besylate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty